Literature DB >> 21160641

Complete response to preoperative chemoradiotherapy in highly advanced gastric adenocarcinoma.

Hironori Shigeoka1, Haruhiko Imamoto, Yasumasa Nishimura, Taro Shimono, Hiroshi Furukawa, Hiroshi Imamura, Takushi Yasuda, Hitoshi Shiozaki.   

Abstract

This report presents a case of highly advanced gastric cancer that achieved a histologically complete response (CR) to preoperative chemoradiotherapy with S-1 plus low-dose Cisplatin. A 60-year-old male patient underwent FDG positron emission tomography (PET) during a routine health examination. The patient was found to have swollen paraaortic lymph nodes. Shortly thereafter, he was diagnosed with gastric carcinoma with a type 2 tumor in the antrum with paraaortic lymph node metastases based on FDG-PET, endoscopic examination and abdominal computed tomography. After the completion of chemoradiation therapy (CRT), the tumor and the paraaortic lymph node metastases disappeared. The patient underwent surgery 5 wk after the completion of CRT, including a subtotal gastrectomy with Roux-en-Y reconstruction, D3 lymph node dissection and a left adrenalectomy. No cancer cells were detected in the resected specimen either in the primary lesion or lymph nodes, thus confirming a pathologically CR to CRT (CR grade 3). The patient has been stable and well without any evidence of recurrence for 48 mo after surgery. Such a preoperative CRT regimen might therefore be very effective for treatment of some advanced gastric cancers.

Entities:  

Keywords:  Chemoradiation; Cisplatin; Complete response; Gastric cancer; Neoadjuvant therapy

Year:  2010        PMID: 21160641      PMCID: PMC2999188          DOI: 10.4251/wjgo.v2.i6.282

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  21 in total

1.  Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome.

Authors:  J A Ajani; P F Mansfield; C H Crane; T T Wu; S Lunagomez; P M Lynch; N Janjan; B Feig; J Faust; J C Yao; R Nivers; J Morris; P W Pisters
Journal:  J Clin Oncol       Date:  2005-02-20       Impact factor: 44.544

2.  Complete response of highly advanced gastric cancer with peritoneal dissemination after new combined chemotherapy of S-1 and low-dose cisplatin: report of a case.

Authors:  M Iwahashi; M Nakamori; M Tani; H Yamaue; S Sakaguchi; M Nakamura; K Ueda; M Ichiro; E Nishino; H Tanimura
Journal:  Oncology       Date:  2001       Impact factor: 2.935

3.  Complete response of a gastric primary after a short but toxic course of 'S-1' EORTC Early Clinical Studies Group.

Authors:  P Schöffski; P Chollet; A Ganser; K H Wiese; E Rambusch; M J de Vries; A Hanauske
Journal:  Ann Oncol       Date:  1999-09       Impact factor: 32.976

Review 4.  Role of radiation therapy in gastric adenocarcinoma.

Authors:  Lisa Hazard; John O'Connor; Courtney Scaife
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

Review 5.  Chemotherapy as a component of multimodal therapy for gastric carcinoma.

Authors:  Yasuhiro Kodera; Michitaka Fujiwara; Masahiko Koike; Akimasa Nakao
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

6.  Preoperative combination chemotherapy with S-1 and low dose cisplatin against highly advanced gastric carcinoma.

Authors:  Yoshiro Saikawa; Yoshikiyo Akasaka; Toshio Kanai; Yoshihide Otani; Koichiro Kumai; Tetsuro Kubota; Masaki Kitajima
Journal:  Oncol Rep       Date:  2003 Mar-Apr       Impact factor: 3.906

7.  S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Authors:  Wasaburo Koizumi; Hiroyuki Narahara; Takuo Hara; Akinori Takagane; Toshikazu Akiya; Masakazu Takagi; Kosei Miyashita; Takashi Nishizaki; Osamu Kobayashi; Wataru Takiyama; Yasushi Toh; Takashi Nagaie; Seiichi Takagi; Yoshitaka Yamamura; Kimihiko Yanaoka; Hiroyuki Orita; Masahiro Takeuchi
Journal:  Lancet Oncol       Date:  2008-02-20       Impact factor: 41.316

8.  Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer.

Authors:  Shunichi Tsujitani; Kenji Fukuda; Nobuaki Kaibara
Journal:  Gastric Cancer       Date:  2003       Impact factor: 7.370

9.  Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation.

Authors:  Tsunehiro Takahashi; Yoshiro Saikawa; Tetsuro Kubota; Yasutada Akiba; Naoyuki Shigematsu; Masashi Yoshida; Yoshihide Otani; Koichiro Kumai; Toshifumi Hibi; Masaki Kitajima
Journal:  Jpn J Clin Oncol       Date:  2003-11       Impact factor: 3.019

10.  Complete response of a highly advanced gastric carcinoma to preoperative chemoradiotherapy with S-1 and low-dose cisplatin.

Authors:  Nobunari Yoshimizu; Yoshiro Saikawa; Tetsuro Kubota; Yasutada Akiba; Masashi Yoshida; Yoshihide Otani; Koichiro Kumai; Toshihumi Hibi; Masaki Kitajima
Journal:  Gastric Cancer       Date:  2003       Impact factor: 7.370

View more
  3 in total

1.  Usefulness of chemoradiotherapy for inoperable gastric cancer.

Authors:  T Taki; Y Hoya; A Watanabe; T Nakayoshi; T Okamoto; H Sekine; N Mitsumori; K Yanaga
Journal:  Ann R Coll Surg Engl       Date:  2016-09-23       Impact factor: 1.891

2.  Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancer.

Authors:  Ivica Ratosa; Irena Oblak; Franc Anderluh; Vaneja Velenik; Jasna But-Hadzic; Ajra Secerov Ermenc; Ana Jeromen
Journal:  Radiol Oncol       Date:  2015-03-25       Impact factor: 2.991

3.  A Case of Peritoneal Dissemination and Splenic Metastasis after Gastric Cancer Surgery That Could Be Controlled with Multidisciplinary Treatment.

Authors:  Nozomi Karakuchi; Senichiro Yanagawa; Daisuke Takei; Shinya Kodama; Yukio Takeshima; Kazuo Sumimoto
Journal:  Case Rep Oncol       Date:  2020-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.